AI-POWERED MINIPROTEIN PLATFORM

Our platform combines de novo and scaffold-guided design with complementary generative AI models. Custom filters built into the de novo pipeline - tuned on our own experimental data - rank and triage designs so only the most progressable candidates advance. We focus on developable miniproteins, whose modular format enables flexible, multispecific architectures.
AI-MPRO drug discovery platform flow, from computational design to best-in-class drug candidates
Stability icon

Stability

Stabilized by strong hydrophobic core and/or disulfide bonds; resistant to protease degradation, hydrolysis, and oxidation.
Developability icon

Developability

Modular format enables multi-epitope targeting via fusions. PK/PD is precisely tunable through format engineering, sustained-release, or chemical modification. Low-cost, versatile manufacturing: synthetic and recombinant.
Efficacy icon

Efficacy

Outstanding (subnanomolar) affinity. Excellent tissue penetration due to small size (max 70 amino acids)
Safety icon of a padlock

Safety

Up to 10,000x selectivity due to large interaction surface. No harmful breakdown products.
Immunogenicity icon

Low immunogenicity

Small size and protease resistance minimize the risk of anti-drug antibody (ADA) formation.
Stability icon

Stability

Stabilized by strong hydrophobic core and/or disulfide bonds; resistant to protease degradation, hydrolysis, and oxidation.
Developability icon

Developability

Modular format enables multi-epitope targeting via fusions. PK/PD is precisely tunable through format engineering, sustained-release, or chemical modification. Low-cost, versatile manufacturing: synthetic and recombinant.
Efficacy icon

Efficacy

Outstanding (subnanomolar) affinity. Excellent tissue penetration due to small size (max 70 amino acids)
Safety icon of a padlock

Safety

Up to 10,000x selectivity due to large interaction surface. No harmful breakdown products.
Immunogenicity icon

Low immunogenicity

Small size and protease resistance minimize the risk of anti-drug antibody (ADA) formation.

Designed for developability. Engineered with precision.

Icon showing a vertical rectangle, a computer monitor, and the letters AI above them, with HPC text below, representing high-performance computing and artificial intelligence.

Structure-Guided Design Strategy

We analyze target structure, accessible interaction surfaces, functional hotspots, and relevant ligand interactions to provide a rational foundation for precise, high-affinity molecular design.

AI-Driven Miniprotein Design and Evaluation

We perform comprehensive structural and functional analysis to identify key interaction sites-such as binding patches and hotspots- on the target protein. This process includes the extraction and alignment of relevant secondary structural motifs from known ligands, forming the foundation for designing high-affinity, structure-based interactions.

Experimental Screening and Functional Validation

Designed scaffolds are evaluated through library-based screening and direct testing to identify active candidates. Selected hits are then validated in functional cell-based assays to confirm target engagement and the desired biological effect.

Precision Engineering

Lead candidates are optimized for affinity, selectivity, and function using advanced display technologies. Next-generation sequencing and machine-learning-assisted data analysis enable efficient exploration and expansion of sequence space, guiding the design of improved variants.
Circular diagram with 'HTS' in the center and three sections connected by green arrows: on the left, a cluster of letters and symbols; on the right, three triangular shapes with green dots underneath; at the bottom, a shaded rectangular box with a symbol resembling a sun or spark.
Illustration of scientific research symbols including a mouse, DNA double helix, syringe, test tubes, and a dropper dispensing liquid into a test tube.

Rapid In Vivo Proof of Concept

Promising candidates advance into in-house in vivo studies for early assessment of biological activity, exposure, and translational potential, enabling faster proof-of-concept decisions.